TLTimothy Lee Lash

Timothy Lee Lash

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Timothy Lee Lash has a total of 431 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hospital-Diagnosed Chronic Diseases and Risk of Colorectal Cancer Recurrence in Stage I to III Patients

    by Jannik Wheler, Jesper Nors, Cathrine F. Hjorth, Frederikke S. Troelsen, Henrik Toft Sørensen, Lene H. Iversen, Timothy L. Lash, Rune Erichsen, Deirdre P. Cronin-Fenton

    Background: Chronic disease prevalence at colorectal cancer diagnosis has increased with population aging. We evaluated the association between chronic diseases prevalent at colorectal cancer resection and recurrence. Methods: This nationwide Danish registry-based cohort study included patients who underwent curative-intent resection for stage I to III colorectal cancer from January 2002 through June 2020. Chronic diseases before resection were ascertained from hospital diagnoses using a modified Charlson Comorbidity Index that omitted malignancies and added five psychiatric disorders (20 diseases). Diseases were grouped into five clinical categories: cardiopulmonary, neurologic, mental health, metabolic, and gastrointestinal. Recurrence was identified using a validated registry-based algorithm. We estimated 1-, 3-, and 5-year cumulative incidences and Cox hazard ratios (HR) with 95% confidence intervals (CI), adjusting for age, sex, calendar year, smoking, alcohol, and body mass index. Results: Among 39,239 patients, 7,326 (19%) developed recurrence within 5 years. Cumulative incidences for patients with versus without chronic disease were 5% versus 5.5% at 1 year, 14.7% versus 15.5% at 3 years, and 18.5% versus 19.6% at 5 years; adjusted HRs were 1.01 (95% CI, 0.96–1.07), 1.03 (0.98–1.08), and 1.03 (0.98–1.08). The 5-year adjusted HR was 1.11 (1.02–1.21) for mental health and 0.79 (0.58–1.07) for neurologic diseases. Conclusions: Prevalent chronic diseases overall were not associated with increased colorectal cancer recurrence risk, although risk was higher with mental health diseases and lower with neurologic diseases. Impact: Poorer survival in patients with colorectal cancer and chronic disease is unlikely to reflect more frequent recurrence. Future studies should clarify whether treatment tolerance contributes to these survival disparities.

  • Open Access

    Representativeness of participants in the Danish National Health Survey in relation to mental disorders and a range of other medical conditions and mortality

    by Katrine Bødkergaard, Mette Lise Lousdal, Timothy L. Lash, Anne Illemann Christensen, Irene Petersen, Oleguer Plana-Ripoll

    Although the Danish National Health Survey (DNHS) uses survey weights to reduce self-selection bias, differences in health status may remain. We explored whether DNHS participants are representative of the general population in Denmark regarding morbidity, particularly mental disorders, and mortality. By individual linkage to administrative registers, we compared DNHS participants ( N = 183,194) with the general population aged 16 years or older ( N = 4,697,047). For 202 health conditions, we estimated period prevalence ratios (PPRs) of having received a diagnosis in the 5 years prior to survey participation and hazard ratios (HRs) of receiving a diagnosis in the subsequent 5 years. Additionally, we estimated mortality HRs, overall and among individuals with prior diagnoses of the specific conditions. Both original weights developed for the DNHS and updated weights better accounting for mental disorders were applied. Overall, weighted survey participants had similar prevalence compared to the general population, but mental disorders were less common before (PPR: 0.86 [0.85; 0.88]) and after (HR: 0.86 [0.84; 0.88]) survey participation. Participants experienced lower all-cause mortality rates than the general population (HR: 0.80 [0.79; 0.82]), especially among those with prior mental disorders (HR: 0.62 [0.59; 0.66]). Applying updated weights resulted in similar mental disorder prevalence (PPR: 0.99 [0.98; 1.01]) but unchanged mortality estimates. The lower mortality among survey participants compared to the general population, especially for individuals with prior mental disorders, suggests that self-selection into participation is not fully accounted for by the original or updated weights. This has implications for the generalisability of DNHS-based analyses.

  • Open Access

    Real-world comparative effectiveness of evolocumab versus ezetimibe in adults with atherosclerotic cardiovascular disease: an active-comparator new-user study

    by Nihar Desai, Ran Jin, Kathleen Hurwitz, Nafeesa N. Dhalwani, Nuvan Rathnayaka, Shia T. Kent, Neil A. Accortt, Timothy L. Lash, Paul Muntner, Chris P. Gale, et al.

  • Use of Sparse Internal Validation Data

    by Timothy L. Lash, Richard F. MacLehose, Thomas P. Ahern, Lindsay J. Collin

    Internal validation sub-studies compare an observed imperfect measurement of a variable with its gold standard measurement in a sample of participants. The gold standard is often expensive or difficult to collect, so the validation sample is usually small. We simulated a small cohort study with a nested, balanced validation sub-study and used the simulated cohorts to evaluate three analytic strategies with the objective of determining which of them, alone or in combination, improved the performance of quantitative bias adjustments informed by the validation sub-study. The strategies were: (1) incorporating a weak prior to the beta distributions assigned to the bias parameters, as opposed to no prior (2) restricting beta distribution assignment to the three predictive values informed by sampling, as opposed to all four predictive values, and (3) restricting imputation of gold-standard measurement to study cohort members who were not sampled for the validation sub-study, as opposed to imputing for all members of the study cohort. All twelve combinations of bias adjustment strategies returned bias-adjusted estimates with less bias and higher coverage than the simulated misclassified cohorts, although all had higher root mean squared errors and wider intervals because of the uncertainty added by incorporating the sparse validation data into the analysis. We found that assigning a prior may sometimes have utility, whereas restricting assignment of beta distributions for use only with sampling and restricting imputation to only cohort members not selected for the validation study adds computational complexity with little utility in return.

  • Re: Survival and “Recurrence With GLP-1 Receptor Agonists in Breast Cancer”

    by Maret L. Maliniak, Julie Barberio, Rebecca Nash, Timothy L. Lash

    Was not provided for this article.

  • Open Access

    History of anxiety, depression, and post-traumatic stress disorder diagnoses among midlife and older transfeminine and transmasculine adults in the United States: A cross-sectional analysis within the STRONG cohort

    by Ethan C. Cicero, Jace D. Flatt, Oumaima Kaabi, Vin Tangpricha, Darios Getahun, Laura McPherson, Timothy L. Lash, Michael J. Silverberg, Suma Vupputuri, Molly Perkins, et al.

  • Open Access

    Sex Differences in Antihypertensive Medications and PTSD Incidence

    by Sophie M Selbe, Péter Szentkúti, Travis C Evans, Timothy L Lash, Jennifer Sumner, Jaimie L Gradus

    Purpose: Evidence suggests there may be a protective association between some antihypertensive medications and posttraumatic stress disorder (PTSD) incidence, but few samples are large enough to examine sex differences in these associations. Methods: Data came from a trauma cohort established from the Danish national registries from 1994 to 2016. All cohort members experienced at least one of the seven potentially traumatic events (PTE). Those exposed redeemed prescriptions for antihypertensive medications (beta blockers, angiotensin II receptor blockers [ARBs], angiotensin-converting enzyme inhibitors [ACE-Is], and calcium channel blockers) within 60 days prior to PTE. For the unexposed group, three persons who never redeemed an antihypertensive medication prescription were matched to each exposed person on age, sex, and time of trauma. The outcome was incident PTSD over 22 years of follow-up (average follow-up time was 5– 6 years). We conducted descriptive analyses followed by Cox proportional hazards regression adjusted for marital status, income, trauma group, Charlson Comorbidity Index score before the PTE, and comedication use of statins, non-steroidal anti-inflammatory drugs, and antidepressants to estimate hazard ratios (HRs) and 95% confidence intervals (CIs). Analyses were sex-stratified. Results: We observed evidence of a protective association between calcium channel blockers and the development of PTSD for females (HR = 0.79; 95% CI = 0.29, 2.2) and males (HR = 0.49; 95% CI = 0.22, 1.1). For females, the adjusted association between ARBs and PTSD was 0.47 (95% CI = 0.11, 2.1); for males, the adjusted association was 1.4 (95% CI = 0.50, 3.6). A slight protective effect was also observed for beta-blockers among males, while these associations closer to the null were observed for females. For both sexes, associations with ACEs were closer to the null. Conclusion: These results suggest possible sex differences in the potentially protective effects of antihypertensive medications on the development of PTSD, although imprecision in measurement indicates results should be interpreted with caution.


  • Lack of relationship between posttraumatic stress disorder and coronary atherosclerotic burden among twin veterans from the Vietnam era

    by Luis C Correia, Amit J Shah, Valeria M Moncayo, Yi-An Ko, Nicholas Smith, Jeffery Osei, Louis Li, Arshed A Quyyumi, J Douglas Bremner, Jack Goldberg, et al.

    Post-traumatic stress disorder (PTSD) has been related to ischemic heart disease (IHD), and the primary substrate for IHD is atherosclerotic burden. We aim to estimate the association between exposure to PTSD and atherosclerotic burden in PTSD-discordant twin pairs. This is a cross-sectional examination of 212 male twins during the 2016-2019 study visit of the Vietnam Era Twin Registry. Current PTSD symptom severity was assessed with the Clinician-Administered PTSD Scale for DSM-IV. PTSD-discordant twins were defined as pairs with different values of the PTSD Symptoms Scale. We regressed the log-transformed CAC Score on the PTSD Scale adjusted for potential confounders using linear mixed models and reported exponentiated coefficients. The sample had a median age of 68 (IQR67-70) years, a 15% prevalence of PTSD (median Symptom Score of 61; IQR53-81), and a median CAC Score of 111 (IQR5-346). The median CAC Score was 69 (IQR0.40-229) in twins with higher PTSD symptoms and 89 (IQR6.6-243) in their brothers with lower PTSD symptoms. The model estimated a -0.95% difference in CAC Score per unit increment in PTSD Symptoms Score within pairs (95%CI -2.6%;+0.7%), not implying a relationship between PTSD and coronary atherosclerosis in a design that inherently controls for familial and early environmental factors.


  • Addressing Measurement Error in Intimate Partner Violence Self-report Data Using Multiple Overimputation and Multidimensional Quantitative Bias Analysis

    by Irina Bergenfeld, Robin A. Richardson, Alexandria R. Hadd, Cari Jo Clark, Regine Haardörfer, Charis Wiltshire, Timothy L. Lash, Angela M. Bengtson

    Background: Intimate partner violence (IPV) is an important global health issue for which measurement error limits public health action. Although most national IPV prevalence estimates come from general health surveys like the Demographic and Health Surveys (DHS), such data probably underestimate prevalence compared with violence-focused surveys. Methods: Using violence-focused surveys conducted in the same country and year (±1) as validation data, we explored two methods of bias adjustment to address measurement error in DHS prevalence estimates. In multidimensional bias analysis, we directly adjusted summary prevalence estimates, using a range of possible sensitivities (10%–100%) and specificities (95%–100%) to elucidate their reasonable bounds. In multiple overimputation, we reestimated all IPV observations, incorporating prior information on measurement error, and averaged prevalence estimates over 50 iterations. Results: Multidimensional bias analysis revealed that an assumption of 95% specificity resulted in negative prevalence estimates in some cases, confirming that false positives are likely negligible. Reasonable sensitivities varied considerably across countries and IPV types, likely due to differences in the number of items used to assess IPV. Multiple overimputation-adjusted estimates were similar to survey estimates, except when unadjusted DHS estimates were <5% and highly discrepant. Past-year estimates were less discrepant than lifetime estimates, suggesting that recall bias may be a factor in underreporting. Conclusion: This study examines measurement error due to IPV underreporting in specific contexts where external information exists, highlighting the need for more accurate IPV assessment using multiple items per domain and for internal validation studies to be incorporated into large-scale surveys.